Lisa Decker
Director/Board Member at CHIMERIX, INC.
Net worth: 466 696 $ as of 29/04/2024
Profile
Lisa L.
Decker is an Independent Director at Chimerix, Inc. since 2023 and the Chief Business Officer at IGM Biosciences, Inc. since 2021.
Previously, she worked as the Associate Director-Technology Licensing at UMass Chan Medical School from 2000 to 2008.
From 2008 to 2019, she served as the Vice President-Business Development at Nektar Therapeutics.
She then became the Chief Business Officer at Atreca, Inc. from 2019 to 2021.
Dr. Decker completed her undergraduate degree at the College of the Holy Cross (Massachusetts) and obtained a doctorate from Tufts University School of Medicine in 1998.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0.18% | 13/03/2024 | 61,006 ( 0.18% ) | 466 696 $ | 29/04/2024 |
Lisa Decker active positions
| Companies | Position | Start |
|---|---|---|
| IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 14/03/2021 |
| CHIMERIX, INC. | Director/Board Member | 27/12/2023 |
Former positions of Lisa Decker
| Companies | Position | End |
|---|---|---|
| ATRECA, INC. | Corporate Officer/Principal | 28/02/2021 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 31/05/2019 |
| UMass Chan Medical School | Corporate Officer/Principal | 31/07/2008 |
Training of Lisa Decker
| Tufts University School of Medicine | Doctorate Degree |
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| ATRECA, INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| IGM Biosciences, Inc. |
- Stock Market
- Insiders
- Lisa Decker
